Thirty-three impotent men underwent pharmacocavernometry and cavernography. Ten patients had a goodclinical response to 60 mg papaverine, nine had a moderate clinical response and in 14, the response was judged to be a poor one. Twelve patients had evidence of abnormal venous leakage from the corpora. Subsequent investigation with isotope phallography showed six patients to have arterial insufficiency and in three of these patients this was amenable to reconstructive vascular surgery.
Pharmacocavernometry in the assessment of erectile impotence Introduction
During the past decade the diagnosis and management of impotence has undergone several advances. In 1982 Virag found that injection of papaverine into the corpus cavernosus produced tumescence and erection'. Vasoactive agents are now widely used in the diagnosis and treatment of impotence'', Patients who fail to respond to papaverine may have abnormalities of either venous drainage or arterial supply. Cavernography has shown that some patients have abnormal venous leakage of blood from the corpora and attempts have been made to treat this abnormality by ligation of these abnormal veins", In other cases, deficiency of the arterial inflow has been demonstrated. Using microvascular surgical techniques attempts have been made to supplement the corporal arterial supply with blood from the inferior epigastric artery'.
These advances have inevitably reached the popular press, leading to an increase in the numbers of patients attending outpatient clinics complaining of impotence. There is now a bewildering array of possible treatment options available to clinicians including hormonal treatment, self-injection therapy, venous ligation, arterial revascularization or the insertion of semirigid or inflatable penile prostheses. There is therefore a need for a reliable investigative programme, to provide an objective assessment of the response to papaverine and also to allow patients to be assigned to appropriate treatment groups, or to further more specific investigations.
The aim of this study was to find out whether pharmacocavernometry fulfilled these criteria.
Patients and methods
Thirty-three patients complaining of erectile impotence underwent a full history and examination. A hormonal screen including testosterone, prolactin, FSH and LH estimations was performed, together with a random blood sugar and liver function tests.
Pharmacocavernometry was performed in every patient. A 21 gauge butterfly needle was inserted into the right corpus cavernosum, a tourniquet was placed around the base of the penis and 60 mg of papaverine injected. The penis was massaged thoroughly and after 2 min the tourniquet was removed. After 15 min, the erectile response was assessed. A good response was one where the penis was sufficiently erect for penetration and the angle between the penis and the thigh was greater than 90 0 with the patient standing.
A moderate response was one where although tumescence had occurred, the penis was not rigid enough for penetration and the angle between the thigh and the penis was less than 90 0 • A poor response was one where little or no tumescence had occurred.
In addition, the pressure rise over 15 min was recorded using a Medex Novatrans MX 800 transducer which had been previously zeroed and positioned at the level of the flaccid penis. Recordings were traced on a Siemens Minograph 82 recorder.
A second 21 gauge butterfly needle was then inserted into the left corpus cavernosum and through this, normal saline was infused using a peristaltic infusion pump at increasing rates from 40 ml/min up to 160 ml/min, or until a fully rigid erection with a pressure rise of more than 80 em water was achieved. The saline was then replaced by 50 ml of half strength contrast (Urografin 150) and the infusion was continued at a rate sufficient to maintain a rigid erection while AP and oblique radiographs were taken to assess the presence of any leakage of contrast from the corpora into the venous system. Finally, the butterfly needles were removed and firm pressure was applied to the puncture sites to minimize bruising. Each patient was reviewed 4 h later to check for the presence of any persistent erection.
Isotope phallography was performed on selected patients by a technique previously described", A bolus of Technitium 99 m labelled human serum albumin was injected into a vein of the antecubital fossa and the activity over the aorto-iliac region, the internal iliac arteries and the penis was measured with a gamma camera (model GE 400fI'). Using a correlation technique" a delay time for the transit of isotope from the aorto-iliac region to the penis was calculated. Control data suggests that a transit time greater than 2.5 s is abnormal".
In those patients with evidence of arterial insufficiency and who were willing to consider penile arterial revascularization, selective pudendal arteriography was performed under general anaesthesia. 
Cavernometrylcavernography
Fourteen patients had a pressure rise of more than 15 cm water following papaverine injection (see Figure 1 ) and they all achieved a full rigid erection, (with a pressure rise in excess of 100 cm water), at a flow rate of 40 mllmin. None of these patients had evidence of venous leakage.
Of the 19 patients who had a pressure response of less than 15 ern water following the injection of papaverine;
(i) eight patients failed to achieve a rigid erection even at flow rates up to 160 ml/min and were diagnosed as having abnormal venous leakage.
(ii) three achieved rigid erections with flow rates less than 60 ml/min. None of these patients had evidence of venous leakage.
(iii) five patients achieved rigid erections with flow rates between 60 and 100 ml/min and two of these patients had cavernographic evidence of contrast in the dorsal vein complex (Figure 2 ) or in the superficial external pudendal veins.
(iv) three patients achieved rigid erections at flow rates greater than 100 mllmin and two of them had evidence of abnormal venous leakage.
One patient had a persistent erection at 4 h which responded well to aspiration of 50 ml blood from the penis. Minor bruising occurred in three patients. (Figure 1 ). Ten patients had a good clinical response to papaverine while in nine patients the response was judged to be a moderate one and in 14 patients the investigator assessed the response as poor. The pressure responses in each group are shown in Figure 1 .
Clinical response to papaverine

Results
Thirty-three patients with a mean age of 53.8 years (range 23-72 years) were studied. The mean duration of symptoms was 3.5 years (range 1-20 years). 
Phallographylarteriography
Phallography was performed on all patients who had a poor clinical response to papaverine but who still achieved rigid erections during infusion cavernometry without evidence of venous leakage (n=7). All but one patient had evidence of arterial insufficiency and of these patients, three underwent selective pudendal arteriography. Two patients had a localized arterial block ( Figure 3 ) while one patient had evidence of an arterio-venous malformation.
Hormonal screen
In two patients a raised prolactin was discovered. One of these patients had renal failure which was felt to be the cause, while in the other patient no cause was found. In all other patients, the hormonal assays were normal. All those with a good pressure response to papaverine (n=14) were offered treatment by self-injection of papaverine of whom eight patients accepted and are currently successfully self injecting. They include two patients with hyperprolactinaemia, who are also being treated with bromocriptine. Patients with evidence of venous leakage were offered surgical venous ligation (n=12). Surgery has been performed to date on four of these patients by a technique previously described", Each of the four patients who underwent this procedure have had some subjective improvement in their spontaneous erectile function, but follow-up is still short (3) (4) (5) (6) months).
Of the patients with arterial insufficiency (n=6), three were offered arterial revascularization (of whom two patients have accepted surgery) and two patients opted for the insertion of penile prostheses. One patient opted to try high dose self injection therapy and has gained some improvement in erectile function using doses of 80-100 mg papaverine in combination with 1 mg phentolamine.
There was one patient with a poor response to papaverine who then required a high flow rate to produce an erection (120 ml/min). There was no evidence of venous leakage or arterial insufficiency and he made a spontaneous recovery following pharmacocavernometry, suggesting that he was suffering from psychogenic impotence. The explanation of this is unclear.
Discussion
The plethora of investigations available for patients with impotence means that it is possible to expend excessive time and money before the appropriate treatment for an individual patient is reached. There is a need for a cheap and reliable plan of investigation.
Cavernometry without the use of vasoactive agents is well described". However, it suffers from the disadvantage of relying upon the production of an erection without activation of either the neurological or pharmacological mechanisms that normally take place during erection. In addition, the volumes of fluid infused may be substantial, with flow rates of more than 300 mllmin often necessary to produce an erection in patients with venous leakage.
Wespes et al. 9 found that the use of papaverine, while reducing the flow rates necessary to produce an erection, gave similar information to simple cavernometry. Pharmacocavernometry, in our hands, overcomes the criticisms levelled against simple cavernometry, while also providing an objective method of assessing the response to papaverine.
We found that the clinical response correlated well with the recorded rise in intracorporeal pressure. However these pressure rises were substantially less than those which are normally expected to produce rigidity (usually 100-150 em waterr'. Certainly, most of the erections produced by the papaverine alone were not rigid, and did not become rigid until saline Was infused, when the intracorporeal pressure rose steeply. This indicates that papaverine alone rarely produces a fully rigid erection, at least under the rather unusual circumstances experienced by the patients in this study and emphasizes that a more reliable measure of a patient's response to papaverine is the result achieved in the privacy of his own home.
Pharmacocavernometry also identified those patients with evidence of venous leakage. In the majority of patients the evidence consisted of a failure to achieve a rigid erection even with high infusion rates while in a proportion of patients there was visualization of contrast in the veins draining the erect penis. Whether this latter group had significant venous leakage is uncertain, given the relatively low flow rates required to produce an erection (which implies that the dynamics of erection were relatively normal).
In addition, the cavernometry results show that patients who have a poor response to papaverine and who require a low flow rate to produce a rigid erection commonly have evidence of arterial insufficiency. Arteriography subsequently confirmed that three of these patients had localized arterial blockage despite the absence of generalized arterial disease.
The technique does have drawbacks in practical terms largely through the time taken to do the test (approximately 30 min) and the fact that it is invasive. Because of this we now prefer to confine this form of investigation to those patients who do not exhibit a good clinical response to papaverine in the outpatient clinic or at home.
The technique is easy to perform and requires little expensive equipment in addition to standard radiographic screening facilities. Many urology departments will have urodynamic equipment already and the acquisition of a second hand peristaltic dialysis pump is inexpensive. We believe that it is a useful investigation in patients with impotence, and especially useful in those with a moderate or poor response to papaverine. It is possible to objectively assess the pressure response to papaverine by pressure measurements and it will identify those patients with venous leakage. For the rest it will direct further appropriate investigation.
